Literature DB >> 12176675

Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers.

H Uemura1, T Yasui, M Kiyokawa, A Kuwahara, H Ikawa, T Matsuzaki, M Maegawa, H Furumoto, M Irahara.   

Abstract

Pregnancy and lactation induce dynamic changes in maternal bone and calcium metabolism. A novel cytokine termed osteoprotegerin (OPG)/osteoclastogenesis-inhibitory factor (OCIF) was recently isolated; this cytokine inhibits osteoclast maturation. To define the effects of pregnancy and lactation on circulating OPG/OCIF in mothers, we studied the changes in the levels of OPG/ OCIF as well as those of calcium-regulating hormones and biochemical markers of bone turnover in the maternal circulation during pregnancy (at 8-11 weeks, at 22-30 weeks, at 35-36 weeks and immediately before delivery) and lactation (at 4 days and at 1 month postpartum). Serum intact parathyroid hormone levels did not change and were almost within the normal range in this period. In contrast, serum 1,25-dihydroxyvitamin D levels increased with gestational age and were above the normal range during pregnancy. After delivery, they fell rapidly and significantly (P<0.01) to the normal range. The levels of serum bone-specific alkaline phosphatase, one of the markers of bone formation, increased with gestational age. After delivery, these levels were further increased at 1 month postpartum. The levels at 1 month postpartum were significantly higher than those at 8-11 and 22-30 weeks of pregnancy (P<0.01 and P<0.05 respectively). The levels of serum C-terminal telopeptides of type I collagen, one of the markers of bone resorption, did not change during pregnancy. After delivery, they rapidly and significantly (P<0.01) rose at 4 days postpartum, and had then fallen by 1 month postpartum. Circulating OPG/OCIF levels gradually increased with gestational age and significantly (P<0.01) increased immediately before delivery to 1.40+/-0.53 ng/ml (means+/-S.D.) compared with those in the non-pregnant, non-lactating controls (0.58+/-0.11 ng/ml). After delivery, they fell rapidly to 0.87+/-0.27 ng/ml at 4 days postpartum and had fallen further by 1 month postpartum. These results suggest that the fall in OPG/OCIF levels may be partially connected with the marked acceleration of bone resorption after delivery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176675     DOI: 10.1677/joe.0.1740353

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  14 in total

1.  Vitamin D insufficiency is prevalent and vitamin D is inversely associated with parathyroid hormone and calcitriol in pregnant adolescents.

Authors:  Bridget E Young; Thomas J McNanley; Elizabeth M Cooper; Allison W McIntyre; Frank Witter; Z Leah Harris; Kimberly O O'Brien
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  Serum 1,25-dihydroxyvitamin D and calcium intake affect rates of bone calcium deposition during pregnancy and the early postpartum period.

Authors:  Kimberly O O'Brien; Carmen M Donangelo; Lorrene D Ritchie; Ginny Gildengorin; Steve Abrams; Janet C King
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

Review 3.  How the reference values for serum parathyroid hormone concentration are (or should be) established?

Authors:  J-C Souberbielle; F Brazier; M-L Piketty; C Cormier; S Minisola; E Cavalier
Journal:  J Endocrinol Invest       Date:  2016-10-01       Impact factor: 4.256

4.  Osteoprotegerin in pregnant adolescents differs by race and is related to infant birth weight z-score.

Authors:  B Essley; T McNanley; B Cooper; A McIntyre; F Witter; Z Harris; K O'Brien
Journal:  J Dev Orig Health Dis       Date:  2011-10       Impact factor: 2.401

5.  Monitoring dynamic interactions between breast cancer cells and human bone tissue in a co-culture model.

Authors:  Christopher H Contag; Wen-Rong Lie; Marie C Bammer; Jonathan W Hardy; Tobi L Schmidt; William J Maloney; Bonnie L King
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

6.  Bone metabolism compensates for the delayed growth in small for gestational age neonates.

Authors:  Roxane Tenta; Ifigeneia Bourgiezi; Evangelos Aliferis; Magdalini Papadopoulou; Antonis Gounaris; Maria Skouroliakou
Journal:  Organogenesis       Date:  2013-01-01       Impact factor: 2.500

7.  Implications of vitamin D deficiency in pregnancy and lactation.

Authors:  Megan L Mulligan; Shaili K Felton; Amy E Riek; Carlos Bernal-Mizrachi
Journal:  Am J Obstet Gynecol       Date:  2009-10-20       Impact factor: 8.661

8.  Serum bone alkaline phosphatase in assessing illness severity of infected neonates in the neonatal intensive care unit.

Authors:  Yaozong Zhang; Chenguang Xue; Tian Zhu; Xiaolan Du; Nan Su; Huabing Qi; Jing Yang; Yuan Shi; Lin Chen
Journal:  Int J Biol Sci       Date:  2011-11-09       Impact factor: 6.580

9.  Expression of osteoprotegerin in placenta and its association with preeclampsia.

Authors:  Pei Shen; Yunhui Gong; Tao Wang; Yueyue Chen; Jin Jia; Shanshan Ni; Bin Zhou; Yapin Song; Lin Zhang; Rong Zhou
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

10.  A case report: pregnancy-induced severe osteoporosis with eight vertebral fractures.

Authors:  Onder Ofluoglu; Demet Ofluoglu
Journal:  Rheumatol Int       Date:  2008-07-17       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.